We share with you the publication of our Life Sciences team for The Legal Industry Reviews in which Andrea Abascal and Anamaría Verdugo analysed the interpretation of the Institute of Public Health regarding the labelling of pharmaceutical products. In their article, they argue that the use of images on secondary packaging can benefit patients by improving the clarity of information, despite the recent restrictive stance taken by the ISP. Check this and more here: Translated with DeepL.com (free version)
